Requirement of tumor-associated antigen-specific CD4 + T cells for an efficient dendritic cell vaccine in antitumor immunotherapy

Author: Simon Thomas   Fonteneau Jean-François   Grégoire Marc  

Publisher: Future Medicine

ISSN: 1750-743X

Source: Immunotherapy, Vol.5, Iss.6, 2013-06, pp. : 565-567

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract